top of page



new panel images_speakers.jpg



Simon Tate

Managing Director

ICG Life Sciences

Simon is a successful entrepreneur and former pharmaceutical executive with over 30 years of experience in drug discovery and development. Simon joined GSK in 1989 and held several senior leadership roles during his 21-year tenure with the company. Simon is an authority in research and development associated with the pain and neuroscience therapeutic areas.
In GSK, Simon established and led the Neurosciences Discovery Technology Group, spanning Psychiatry and Neurology target validation and biomarker discovery and also established the Department of Gene Expression and Protein Biochemistry in the UK. In his role as VP and Head of Pain, Epilepsy and Migraine Drug Discovery and Development, Simon delivered successful proof of concept studies in chronic pain, high quality clinical candidates and innovative novel targets. During his time at GSK, Simon was also involved in several late-stage clinical program teams.
In 2010 Simon led the GSK spin-off of Convergence Pharmaceuticals, as Chief Scientific Officer. Simon led all Research and Development activities for Convergence, which in a short time became widely recognized as one of the leading companies in the field of pain and ion channel drug discovery and development. In 2014, Convergence reported successful clinical proof of concept studies with outstanding efficacy and safety in both trigeminal neuralgia and pain associated with sciatica. In 2015, the company was sold to Biogen for $675 million. Simon become Vice President and Head of Pain Therapeutic Area at Biogen for three years. In 2018 Simon co-founded Bridge Valley Ventures, a life sciences ventures capital company, prior to transitioning to ICG Capital in 2021.

Media Partners

Savvy Investor 2019.jpg
SPS Annual Dutch Pension Funds & Institutional Investors Conference, Amsterdam
September 26, 2023
Courtyard by Marriot Amsterdam Airport
SPS Nordic Pension Fund & Institutional Investors' Annual Conference, Stockholm
October 5, 2023
7A Strandvägen, Stockholm
SPS LGPS Sustainable Investment & Other Topical Issues Conference
October 19, 2023
The View at the Royal College of Surgeons, London
SPS Current Investment Issues for Pension Funds
November 9, 2023
The View at the Royal College of Surgeons, London
SPS Annual Bond Investment Conference
January 11, 2024
SPS ESG Investment & Current Issues Conference
February 14, 2024
SPS Annual Nordic Investment Conference, Copenhagen
March 5, 2024
SPS Local Authority Pension Funds' Annual Investment Conference
March 13, 2024
SPS Annual Northern Investment Conference
March 21, 2024
SPS Annual Investment Strategies Conference
April 16, 2024
SPS Swiss Institutional Investors' Conference
April 25, 2024
SPS Nordic Sustainable Investment Conference
May 9, 2024
SPS Alternative and Real Asset Investments Conference
May 16, 2024
SPS Irish Pension Funds' Annual Investment & Current Issues Conference
June 11, 2024
SPS Fiduciary, OCIO and Investment Governance for Pension Funds
July 11, 2024
SPS Optimising Value in Bond Investments Conference, London
September 5, 2024
SPS Dutch Investors' Annual Investment & Current Issues Conference
September 17, 2024
SPS Finland Investors' Summit
September 26. 2024
SPS Sustainable Investments & Climate Change Issues Conference
October 9, 2024
SPS Local Authority Pension Funds' ESG & Current Issues Conference
October 22, 2024
SPS Current Investment Issues for Pension Funds
November 7, 2024
SPS Nordic Institutional Investors' Annual Conference, Stockholm
November 13, 2024
SPS DC Pension Funds Update, London
December 10, 2024
bottom of page